Skip to content
Search

Latest Stories

LloydsPharmacy opens new dispensary at Salisbury

LloydsPharmacy has opened a new dispensary to allow patients at Salisbury Hospital a faster and more convenient pharmacy experience.

The multiple was selected to operate an outpatient pharmacy situated within the hospital site after its bid in May 2020 was deemed successful by Salisbury NHS Foundation Trust.


Kieran Doona, head of Healthcare and NHS Pharmacy Services for McKesson UK, parent company to LloydsPharmacy, commented: “We all know that trips to hospital can be stressful, which is why improving and making a difference to that experience is one of our key objectives.

"We understand that outpatients want to be able to collect their medicine without having to wait too long, and this partnership is all about ensuring our services are as effective, efficient and as patient-focused as possible, whilst helping to drive efficiencies for the Trust and free them up to focus on more urgent care needs.”

As well a faster and more convenient pharmacy experience, patients, hospital staff and visitors can now access a limited range of over-the-counter products, including pain medication, skincare products and toiletries.

In addition to dispensing around 62,000 items each year, the pharmacy can also provide advice and support for patients who have any questions about their health or treatment regime.

Steve Bleakley, chief pharmacist for Salisbury Hospital, said “It’s great to be working in partnership with LloydsPharmacy to provide our outpatients with an improved experience and purpose-built unit. The project has wide reaching benefits allowing hospital pharmacy staff to be redeployed towards improving patient safety and efficiency on the front line”.

LloydsPharmacy operates over 47 outpatient dispensaries across the country after the multiple opened the first one in November 2009 in Liverpool.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less